ETHK Labs Inc. (HKG:1931)

Market Cap	569.52M -94.8%
Revenue (ttm)	3.35B -5.6%
Net Income	-86.21M
EPS	-0.05
Shares Out	1.60B
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	286,000
Open	0.3450
Previous Close	0.3400
Day's Range	0.3450 - 0.3650
52-Week Range	0.3300 - 8.7900
Beta	-0.32
Analysts	n/a
Price Target	n/a
Est. Earnings	Dec 1, 2026

About ETHK Labs

ETHK Labs Inc., an investment holding company, distributes In vitro diagnostic (IVD) products in Mainland China and internationally. The company operates through three segments: Distribution Business, After-sales Services, and Self-branded Products Business. It offers IVD analysers, reagents, and other consumables for various IVD testing categories, including hematology and body fluid, immunoassay, clinical chemistry, immunology, microbiology, and point-of-care testing. The company also provides haemostasis products; solution services to the cl...

• Industry: Medical Distribution
• Sector: Healthcare
• Founded: 2016
• Employees: 4,386
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 1931

Financial Performance

In 2025, ETHK Labs's revenue was 2.82 billion, a decrease of -10.81% compared to the previous year's 3.16 billion. Earnings were 34.93 million, a decrease of -86.59%.

Financial numbers in CNY

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Nov 11, 2026

Data Sources Report a data error